Skip to main content

Exact Sciences Value Stock - Dividend - Research Selection

Exact sciences

ISIN: US30063P1057 , WKN: 590273

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note

2024-04-24
In the latest trading session, Exact Sciences (EXAS) closed at $63.24, marking a -0.46% move from the previous day.

Here’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)

2024-04-24
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]

Artisan Mid Cap Fund Q1 2024 Commentary

2024-04-24
Artisan Mid Cap Fund's portfolio outperformed the Russell Midcap® Growth Index in Q1 2024. Click here to read the full fund letter.

Baron Health Care Fund Q1 2024 Shareholder Letter

2024-04-23
In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared with the 8.52% gain for the Russell 3000 Health Care Index and the 10.56% gain for the S&P 500 Index.

Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?

2024-04-22
Exact Sciences' (EXAS) first-quarter 2024 performance is expected to include gains from robust Cologuard uptake and continuing Oncotype DX growth, offset slightly by increasing operating costs.

10 Best Performing Biotech ETFs in 2024

2024-04-22
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2024 Update

2024-04-19
ARK Invest's 13F portfolio value decreased by 15% this quarter, with the number of holdings increasing from 223 to 230. Click here for a detailed analysis.

Why Exact Sciences (EXAS) Dipped More Than Broader Market Today

2024-04-17
Exact Sciences (EXAS) concluded the recent trading session at $63.22, signifying a -1% move from its prior day's close.

Exact Sciences Corporation's (NASDAQ:EXAS) Profit Outlook

2024-04-17
With the business potentially at an important milestone, we thought we'd take a closer look at Exact Sciences...

Exact Sciences names Aaron Bloomer CFO

2024-04-15
The executive will succeed Jeff Elliott, who said in January he would step down due to personal reasons.